What are Active Pharmaceutical Ingredients (APIs)?
Active Pharmaceutical Ingredients (APIs) are chemically defined compounds responsible for the therapeutic effect of medicinal products.
In the context of industrial water and wastewater treatment, the term refers to pharmaceutical substances that enter liquid waste streams during the manufacture, processing or cleaning of pharmaceutical products.
Due to their stable molecular structures, biological activity and potential environmental impact, APIs represent one of the most significant contaminant groups in pharmaceutical wastewater treatment.
How are APIs Generated in Wastewater?
APIs enter wastewater through a variety of pharmaceutical manufacturing processes, including:
- Chemical synthesis involving reaction mixtures, intermediates and by-products
- Formulation processes using suspensions, solutions and pharmaceutical excipients
- Cleaning-in-Place (CIP) operations, generating residues from reactors, mixers and pipelines
- Laboratory and pilot plant activities, producing smaller quantities of wastewater during research and development
- Batch failures and accidental releases, resulting in uncontrolled API discharges
The composition of API-containing wastewater varies considerably depending on the active ingredients produced, synthesis routes and auxiliary chemicals used.
What Are the Objectives of Wastewater Treatment?
The treatment of API-containing wastewater pursues several technical and regulatory objectives:
- reducing biologically active substances to minimise ecotoxicological impacts
- degrading persistent organic compounds
- removing Adsorbable Organic Halogens (AOX) associated with halogenated APIs
- reducing Chemical Oxygen Demand (COD) and Total Organic Carbon (TOC)
- preventing the development of antimicrobial resistance through the removal of antibiotic residues
- protecting biological wastewater treatment processes against toxicity and inhibition
How Does API Wastewater Treatment Work?
Wastewater containing pharmaceutical active ingredients is generally treated using multi-stage treatment systems.
Mechanical and Physical Pre-treatment
Typical pre-treatment processes include:
- screening and filtration to remove suspended solids
- equalisation tanks to balance fluctuating wastewater loads
Physico-Chemical Treatment
Depending on wastewater composition, common treatment technologies include:
- coagulation and flocculation for removing colloidal contaminants
- activated carbon adsorption for persistent organic compounds
- advanced oxidation processes (AOPs), such as ozonation or UV/H₂O₂, to break down complex API molecules
Biological Treatment
Biological treatment is typically used to remove readily biodegradable organic compounds.
Common technologies include:
- activated sludge systems
- membrane bioreactors (MBRs), combining biological degradation with membrane filtration
End-of-Pipe Technologies
To remove residual pharmaceutical compounds, advanced polishing processes may include:
Typical parameters of wastewater containing active pharmaceutical ingredients
- COD (Chemical Oxygen Demand)
- TOC (Total Organic Carbon)
- AOX in the case of halogenated compounds
- Active substances such as antibiotics, hormones or analgesics
- Solvent residues (e.g. ethanol, acetone)
- Fluctuating pH value
- Toxicity to biological processes
Disposal and water reuse
Depending on the level of contamination, different strategies are employed:
- Discharge to municipal sewage treatment works following pre-treatment
- Multi-stage industrial wastewater treatment
- Internal reuse as process water or service water
- Thermal disposal of highly concentrated effluents
This water is not intended for use as drinking water.
Regulatory requirements for wastewater containing APIs
Treatment is subject to strict regulatory requirements:
These regulations set out limit values and requirements for the safe treatment and disposal of such wastewater.
